Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

What older adults do on screens may matter more than total screen time

29

Sep 2026

What older adults do on screens may matter more than total screen time

Across 8,996 older adults in four cohorts, television viewing was associated with poorer global cognition, while computer use was associated with better cognitive performance, with the strongest positive associations at low-to-moderate levels of use. Mendelian randomization supported these opposing patterns and linked genetically predicted television viewing time to lower left insula volume, which accounted for an estimated 14.8% of its association with poorer cognitive performance.

Social connection has a price, and it varies from person to person

29

Sep 2026

Social connection has a price, and it varies from person to person

Researchers found that people were willing to spend slightly more on social than on non-social experiences, suggesting that companionship has measurable economic value. Greater perceived social support was associated with more social choices and spending, while higher autistic-trait scores and broader social dysfunction were associated with lower valuation of social experiences.

People make first choices faster as outcomes grow less predictable, study finds

29

Sep 2026

People make first choices faster as outcomes grow less predictable, study finds

In three online experiments involving 300 US adults, researchers varied how reliably rewards matched their labels, how often rewards changed, and whether chosen movements went as intended. Participants responded faster before their first choice as randomness increased, while computational models suggested they used simpler, less precise decision policies.

First EU Screening Week urges citizens to know their numbers

29

Sep 2026

First EU Screening Week urges citizens to know their numbers

At a dedicated press conference at the EASD Annual Meeting in Milan, organized by the European Diabetes Forum (EUDF), three leading European cardiometabolic scientific associations - the European Society of Cardiology (ESC), the European Association for the Study of Diabetes (EASD) and the European Association for the Study of Obesity (EASO) - joined European Commissioner for Health and Animal Welfare Olivér Várhelyi to welcome the launch of the first-ever EU Screening Week.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Mercury Pharmaceuticals
Mercury Pharmaceuticals

Why Us?

KNOWLEDGE OF RESEARCH ENVIRONMENT

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.

UNDERSTANDING INDUSTRIAL NEEDS

Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.

FOCUSED PROJECT MANAGEMENT

Smart approach to project management that helps speed up development stages and decision making.

INVESTMENT CAPABILITY

Availability of own investment up to 2m€ per project allows us to reach the next value milestone.